文献速递银屑病与炎症性皮肤病皮肤感染

美国银屑病成人患者再入院预测因素

Predictors of hospital readmission in United States adults with psoriasis.
PubMed 文献 · J Am Acad Dermatol · 2019-10-31

基于2012-2014年美国全国再入院数据库分析2606例银屑病住院患者,银屑病相关再入院率为8.3%,全因再入院率为35.2%。银屑病再入院与住院≥6天、教学医院、合并皮肤感染及秋季住院相关,2012至2014年银屑病再入院呈上升趋势。

要点

  • 银屑病住院患者全因再入院率高达35.2%,但银屑病本身再入院率仅8.3%。
  • 住院≥6天、教学医院、合并皮肤感染和秋季住院与银屑病再入院正相关。
  • 银屑病再入院从2012到2014年增加,少数患者反复住院贡献大部分费用。

核心结论

  • 银屑病住院患者整体再入院率高,但银屑病本身再入院率低。
  • 部分银屑病患者反复住院,承担了大部分住院费用。

研究设计与样本

  • 分析2012-2014年美国全国再入院数据库,纳入2606例银屑病住院。
  • 采用多变量回归模型分析再入院预测因素。

主要发现

  • 2606例银屑病住院中,216例有≥1次银屑病再入院,患病率8.3%(95%CI 6.6%-10.0%)。
  • 918例有全因再入院,患病率35.2%(95%CI 32.2%-38.3%)。
  • 首次再入院年均费用为3,500,141美元,后续再入院为8,357,961美元。
  • 银屑病再入院与住院≥6天(aHR 1.82,95%CI 1.06-3.12)、教学医院(1.93,1.13-3.31)、合并皮肤感染(2.13,1.11-4.08)、秋季住院(4.51,2.54-8.00)相关。
  • 其他感染与银屑病再入院负相关(aHR 0.49,95%CI 0.26-0.92),银屑病再入院从2012到2014年增加(aHR 1.93,95%CI 1.26-2.93)。

临床怎么用

  • 对住院≥6天、教学医院、合并皮肤感染或秋季住院的银屑病患者应关注再入院风险。
  • 需针对反复住院的银屑病患者制定干预措施以降低再入院率。

局限性

  • 缺乏银屑病特征数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies showed a large inpatient burden of psoriasis in the United States. Less is known about the hospital readmission for psoriasis. OBJECTIVES: To determine the patterns and predictors of hospital readmission rates for psoriasis. METHODS: We analyzed data from the 2012-2014 Nationwide Readmissions Database, a representative sample of hospital readmissions in the United States. RESULTS: Among 2606 admissions for psoriasis, 216 had ≥1 readmissions for psoriasis (prevalence [95% confidence interval]: 8.3% [6.6%-10.0%]) and 918 for all-causes (35.2% [32.2%-38.3%]). The mean annual cost of first readmission for any reason was $3,500,141, with $8,357,961 for subsequent readmissions. In multivariable regression models, readmission for psoriasis was associated with ≥6 day-long index hospitalization (adjusted hazard ratio [95% confidence interval]: 1.82 [1.06-3.12]), teaching hospital (1.93 [1.13-3.31]), comorbid skin infection (2.13 [1.11-4.08]), and hospitalization in the autumn (4.51 [2.54-8.00]), but inversely associated with other infections (0.49 [0.26-0.92]). Readmissions for psoriasis increased from 2012 to 2014 (1.93 [1.26-2.93]). LIMITATIONS: No data on psoriasis characteristics. CONCLUSION: Inpatients with psoriasis had high rates of readmission overall but low rates of readmission for psoriasis per se. A subset of psoriasis patients was hospitalized repeatedly and responsible for most inpatients costs. Future interventions are needed to lower readmission rates among psoriasis patients.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Cheng BT, Silverberg JI. Predictors of hospital readmission in United States adults with psoriasis. J Am Acad Dermatol. 2019. PMID: 31678328. doi:10.1016/j.jaad.2019.10.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。